Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 349 results for "Victoza"

More LEADER: Liraglutide Delays Progression of Renal Events

MUNICH The glucagonlike-peptide 2 (GLP-1) agonist liraglutide ( Victoza , Novo Nordisk) delays progression of renal events — in particular, new-onset persistent macroalbuminuria — in patients with type 2 diabetes, according to the latest data ... Diabetes Care, 1 month ago

28 images for Victoza

Pharma Letter, 1 month ago
DataMonitor HealthCare, 1 month ago
Pharma Letter, 1 month ago
BioPharma Dive, 1 month ago
FiercePharma, 2 months ago
Pharmafile, 2 months ago
FiercePharma, 3 months ago
diaTribe, 3 months ago
Nasdaq, 3 months ago
diaTribe, 3 months ago

Liraglutide reduces progression of kidney damage

Treatment with liraglutide (Victoza) reduces the progression of kidney damage when added to standard of care in adults with type 2 diabetes at high cardiovascular risk, according to data presented at the European Association for the study of ...
 Prescriber1 month ago Victoza® lowers the risk of microvascular events in the kidney in adults with type 2 diabetes at high CV risk  PharmiWeb1 month ago Victoza® lowered the progression of kidney damage in adults with type 2 diabetes at high CV risk  PR Newswire India1 month ago Victoza® lowers progression of kidney damage in diabetic adults at high CV risk  Hospital Pharmacy Europe1 month ago
DataMonitor HealthCare

EASD 2016: Renal benefit seen with Victoza in LEADER 3 unlikely to lead to label expansion

Additional data from Victoza's (liraglutide; Novo Nordisk) LEADER 3 cardiovascular outcomes trial in type 2 diabetes were presented on 15 September 2016 at the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2016).
 DataMonitor HealthCare1 month ago Diabetes Medicine Victoza in Clinical Trial for Parkinson's Disease Treatment  Parkinson'sNewsToday.com1 month ago Trial Scorecard: FIGHT  Healio1 month ago Mixed Results for Liraglutide in Type 1 Diabetes: ADJUNCT 1, 2  General Medicine eJournal2 months ago
Pharma Letter

Semaglutide and Victoza data show Novo Nordisk progress in type 2 diabetes

Novo Nordisk has presented promising data both on a Phase III drug and an existing product at
 Pharma Letter1 month ago Victoza May Reduce Heart Disease Risk  Diabetes Forecast1 month ago New Diabetes Drug Research Highlights from EASD  diaTribe1 week ago EASD 2016: Novo Nordisk presents detailed results on semaglutide's CV benefit  DataMonitor HealthCare1 month ago

Report finds Sanofi GLP-1 med has safety edge over Victoza

Having just won an FDA nod for its GLP-1 diabetes contender Adlyxin, Sanofi will be going up against some entrenched rivals in its fight for market share. But new data from healthcare informatics firm Advera Health show it might have a safety edge ...
 FiercePharma2 months ago The Diabetes Price War Claims Casualties  Bloomberg3 weeks ago Google alliance Onduo central to Sanofi's diabetes revival  pharmaphorum1 month ago Diabetes DTC advertising skyrockets as Novo, Sanofi and Lilly vie for share  FiercePharma1 month ago
BioPharma Dive

Novo's Victoza follow-on showing heart benefits

Dive Brief: Novo Nordisk announced positive data for its once-weekly glucagon-like peptide (GLP)-1 semaglutide at the 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Germany Friday morning. Results from the ...
 BioPharma Dive1 month ago Novo Nordisk stokes GLP-1 hopes as weekly semaglutide slashes heart risks by 26%  FiercePharma1 month ago Novo pits prospect semaglutide against Victoza, Jardiance  FiercePharma2 months ago

Victoza (liraglutide)

GENERIC NAME: liraglutide BRAND NAME: Victoza PRESCRIPTION: Yes GENERIC AVAILABLE: No USES: WARNING (BLACK BOX WARNING): Victoza causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors in rats and mice. It is ...
 MedicineNet.com1 month ago Scottish Medicines Consortium liraglutide (Victoza)  FirstWord Pharma1 month ago
BioPharma Dive

Novo Nordisk faces delay for insulin combo

Dive Brief: Novo Nordisk announced on Friday its fixed-dose combination of Tresiba, a type of insulin degludec, and Victoza (liraglutide), its GLP-1 inhibitor, has been delayed by the U.S. Food and Drug Administration. A final decision for the ...
 BioPharma Dive1 month ago Novo's Insulin/GLP-1 Agonist Combo IDegLira Delayed in US  General Medicine eJournal1 month ago

Analyst Notes: Just how healthy are the leading T2DM brands in the EU and the US?

Type 2 diabetes mellitus: FirstView survey reports on loyalty and perceptions of leading brands In the closely fought brand loyalty stakes, some type 2 diabetes mellitus (T2DM) drugs are gaining more traction than others. A new FirstView report ...
 FirstWord Pharma15 hours ago

Weather Channels Its Inner Nerd: Uses Science To Attract Viewers, Brands Too

Weather isn't just about life-and-death events: tornados, hurricanes, floods, etc. Increasingly, it's about something a bit lower key, less emotional and more cerebral: science. On a recent Weather Center Live segment on The Weather Channel the ...
 Media Post1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Victoza
Get updated on latest news & your favorite topics right in your inbox!
More     Less